abstract |
The present invention relates to anhydrous and hydrate forms of N- (3-ethynylphenyl) -6,7-bis (2-methoxyethoxy) -4-quinazolinamine mesylate. The invention also relates to pharmaceutical compositions for treating hyperproliferative disorders, such as cancer, containing such compounds. SHE |